Corporate Profile for Ventana Medical Systems Inc., dated March 15, 2002.Business Editors --(BUSINESS WIRE) The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services. -0-
Published Date: March 15, 2002
Company Name: Ventana Medical Systems Inc.
Address: 1910 Innovation Park Drive
Tucson, AZ 85737
Main Telephone
Number: 800/227-2155
Internet Home
Page Address
(URL): www.ventanamed.com
Chief Executive
Officer: Christopher M. Gleeson
Chief Financial
Officer: Nicholas Malden
Investor Relations
Contact: Sue Schindel
Business number: 520/229-3915
E-mail address: sschindel@ventanamed.com
Public Relations
Contact: Sue Schindel
Business number: 520/229-3915
E-mail address: sschindel@ventanamed.com
Industry: Medical
Trading Symbol/
Exchange: Nasdaq: VMSI
Company description: Ventana Ventana Medical Ventana Medical is one of the world’s leading developers and manufacturers of medical diagnostic instrument and reagent systems providing leading-edge automation technology for use in slide-based diagnosis of cancer and infectious disease. develops, manufactures and markets instrument/reagent systems that automate To turn a set of manual steps into an operation that goes by itself. See automation. tissue preparation and slide staining staining /stain·ing/ (stan´ing) 1. artificial coloration of a substance to facilitate examination of tissues, microorganisms, or other cells under the microscope. For various techniques, see under stain. 2. in clinical histology histology (hĭstŏl`əjē), study of the groups of specialized cells called tissues that are found in most multicellular plants and animals. and drug discovery laboratories worldwide. Ventana's clinical systems are important tolls used in the diagnosis and treatment of cancer and infectious diseases infectious diseases: see communicable diseases. . Ventana's drug discovery systems are used to accelerate the discovery of new drug targets and evaluate the safety of new drug compounds. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion